| Literature DB >> 35065274 |
Paolin Rocio Cáceres-Vélez1, Flora Hui2, Julie Hercus1, Bang Bui3, Patricia Regina Jusuf4.
Abstract
As human life expectancy increases, age-related health issues including neurodegenerative diseases continue to rise. Regardless of genetic or environmental factors, many neurodegenerative conditions share common pathological mechanisms, such as oxidative stress, a hallmark of many age-related health burdens. In this review, we describe oxidative damage and mitochondrial dysfunction in glaucoma, an age-related neurodegenerative eye disease affecting 80 million people worldwide. We consider therapeutic approaches used to counteract oxidative stress in glaucoma, including untapped treatment options such as novel plant-derived antioxidant compounds that can reduce oxidative stress and prevent neuronal loss. We summarize the current pre-clinical models and clinical work exploring the therapeutic potential of a range of candidate plant-derived antioxidant compounds. Finally, we explore advances in drug delivery systems, particular those employing nanotechnology-based carriers which hold significant promise as a carrier for antioxidants to treat age-related disease, thus reviewing the key current state of all of the aspects required towards translation.Entities:
Keywords: Age-related disease; Antioxidant therapy; Glaucoma; Mitochondrial dysfunction; Nanotechnology; Oxidative stress
Mesh:
Substances:
Year: 2022 PMID: 35065274 DOI: 10.1016/j.arr.2022.101572
Source DB: PubMed Journal: Ageing Res Rev ISSN: 1568-1637 Impact factor: 10.895